These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33133336)

  • 1. Lidose-Isotretinoin Administered Without Food Improves Quality of Life in Patients With Severe Recalcitrant Nodular Acne: An Open-Label, Single-Arm, Phase IV Study.
    Zaenglein AL; Segal J; Darby C; Del Rosso JQ
    J Clin Aesthet Dermatol; 2020 Sep; 13(9):15-20. PubMed ID: 33133336
    [No Abstract]   [Full Text] [Related]  

  • 2. An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period.
    Del Rosso JQ; Stein Gold L; Segal J; Zaenglein AL
    J Clin Aesthet Dermatol; 2019 Nov; 12(11):13-18. PubMed ID: 32038751
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne.
    Webster GF; Leyden JJ; Gross JA
    J Drugs Dermatol; 2014 Jun; 13(6):665-70. PubMed ID: 24918555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne.
    Del Rosso JQ; Kircik L
    J Drugs Dermatol; 2024 Jun; 23(6):423-428. PubMed ID: 38834211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotretinoin 5 mg daily for low-grade adult acne vulgaris--a placebo-controlled, randomized double-blind study.
    Rademaker M; Wishart JM; Birchall NM
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):747-54. PubMed ID: 23617693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne.
    Strauss JS; Leyden JJ; Lucky AW; Lookingbill DP; Drake LA; Hanifin JM; Lowe NJ; Jones TM; Stewart DM; Jarratt MT; Katz I; Pariser DM; Pariser RJ; Tschen E; Chalker DK; Rafal ES; Savin RP; Roth HL; Chang LK; Baginski DJ; Kempers S; McLane J; Eberhardt D; Leach EE; Bryce G; Hong J
    J Am Acad Dermatol; 2001 Aug; 45(2):187-95. PubMed ID: 11464179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.
    DiGiovanna JJ; Langman CB; Tschen EH; Jones T; Menter A; Lowe NJ; Eichenfield L; Hebert AA; Pariser D; Savin RP; Smith SR; Jarratt M; Rodriguez D; Chalker DK; Kempers S; Ling M; Rafal ES; Sullivan S; Kang S; Shah LP; Wu E; Newhouse J; Pak J; Eberhardt DR; Bryce GF; McLane JA; Ondovik M; Chin C; Khoo KC; Rich P
    J Am Acad Dermatol; 2004 Nov; 51(5):709-17. PubMed ID: 15523348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Pharmacokinetic Profiles of a Novel Low-dose Micronized-isotretinoin 32 mg Formulation and Lidose-isotretinoin 40 mg in Fed and Fasted Conditions: Two Open-label, Randomized, Crossover Studies in Healthy Adult Participants.
    Madan S; Kumar S; Segal J
    Acta Derm Venereol; 2020 Feb; 100(4):adv00049. PubMed ID: 31774544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin.
    Del Rosso JQ; Stein Gold L; Johnson SM; Rueda MJ; Baldwin H; Lain EL; Landis M; Rendon M; Tanghetti E; Weiss J
    J Drugs Dermatol; 2018 Mar; 17(3):264-273. PubMed ID: 29537444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study.
    Webster GF; Leyden JJ; Gross JA
    J Am Acad Dermatol; 2013 Nov; 69(5):762-767. PubMed ID: 23953888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for Use of Micronized Isotretinoin for Treatment of Acne Vulgaris: Practical Considerations and Therapeutic Advantages.
    Del Rosso JQ
    J Clin Aesthet Dermatol; 2023 Sep; 16(9):20-24. PubMed ID: 37720199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density.
    Hoover KB; Miller CG; Galante NC; Langman CB
    Osteoporos Int; 2015 Oct; 26(10):2441-7. PubMed ID: 25956286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.
    Stein Gold L; Pariser DM; Guenin E
    J Drugs Dermatol; 2019 Dec; 18(12):1218-1225. PubMed ID: 31860209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms.
    McGrath EJ; Lovell CR; Gillison F; Darvay A; Hickey JR; Skevington SM
    Br J Dermatol; 2010 Dec; 163(6):1323-9. PubMed ID: 21137117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Formulations of Isotretinoin for Acne Treatment: Expanded Options and Clinical Implications.
    Bellomo R; Brunner M; Tadjally E
    J Clin Aesthet Dermatol; 2021 Dec; 14(12 Suppl 1):S18-S23. PubMed ID: 35291260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.
    Harper JC; Baldwin H; Stein Gold L; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1147-1154. PubMed ID: 31741360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.
    Lain E; Day D; Harper J; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1128-1138. PubMed ID: 31741356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the efficacy and safety of a combination of 2 topical retinoids (RetinSphere) in maintaining post-treatment response of acne to oral isotretinoin.
    Truchuelo MT; Jiménez N; Mavura D; Jaén P
    Actas Dermosifiliogr; 2015 Mar; 106(2):126-32. PubMed ID: 25306870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.
    Strauss JS; Leyden JJ; Lucky AW; Lookingbill DP; Drake LA; Hanifin JM; Lowe NJ; Jones TM; Stewart DM; Jarratt MT; Katz I; Pariser DM; Pariser RJ; Tschen E; Chalker DK; Rafal ES; Savin RP; Roth HL; Chang LK; Baginski DJ; Kempers S; McLane J; Eberhardt D; Leach EE; Bryce G; Hong J
    J Am Acad Dermatol; 2001 Aug; 45(2):196-207. PubMed ID: 11464180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.